They realized that if they “release” these breaks, tomatoes could become much sweeter. They used CRISPR-Cas9 gene-editing ...

Gene therapy can effectively treat various diseases, but for some debilitating conditions like muscular dystrophies there is ...

Citi initiates coverage of Gilead Sciences and Vertex Pharmaceuticals at buy in the large U.S. biotech sector. Read more here.

Today’s mass-produced tomatoes often grow to palm-sized proportions, but their naturally occurring ancestors were far smaller ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

I n a groundbreaking study published in the journal Nature, researchers have successfully used gene editing to create sweeter ...

In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, ...

In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for ...

Selection for bigger tomatoes has made the fruits less sweet, but now it has been shown that gene editing can make them ...

These three emerging technology leaders are pioneering quantum computing, gene editing, and electric aviation.